313 results on '"Uibu T"'
Search Results
2. Risk factors of clinically significant complications in transbronchial lung cryobiopsy:a prospective multi-center study
- Author
-
Mononen, M. (Minna), Saari, E. (Eeva), Hasala, H. (Hannele), Kettunen, H.-P. (Hannu-Pekka), Suoranta, S. (Sanna), Nurmi, H. (Hanna), Randell, J. (Jukka), Laurikka, J. (Jari), Uibu, T. (Toomas), Koskela, H. (Heikki), Kaarteenaho, R. (Riitta), Purokivi, M. (Minna), Mononen, M. (Minna), Saari, E. (Eeva), Hasala, H. (Hannele), Kettunen, H.-P. (Hannu-Pekka), Suoranta, S. (Sanna), Nurmi, H. (Hanna), Randell, J. (Jukka), Laurikka, J. (Jari), Uibu, T. (Toomas), Koskela, H. (Heikki), Kaarteenaho, R. (Riitta), and Purokivi, M. (Minna)
- Abstract
Background: The use of a transbronchial lung cryobiopsy (TBLC) is increasing as a diagnostic method of interstitial lung diseases (ILD). This study aimed to evaluate risk factors associated with clinically significant complications of TBLC in ILD patients. Methods: Patients referred to Kuopio or Tampere university hospitals, in Finland, for a suspected ILD were included. The TBLC was performed in an outpatient setting for 100 patients. Patients were mechanically ventilated in general anesthesia. Fluoroscopy guidance and prophylactic bronchial balloon were used. Complications, such as bleeding, pneumothorax, infections, and mortality were recorded. Moderate or serious bleeding, pneumothorax, or death ≤90 days were defined as clinically significant complications. A multivariable model was created to assess clinically significant complications. Results: The extent of traction bronchiectasis (Odds ratio [OR] 1.30, Confidence interval [CI] 1.03–1.65, p = 0.027) and young age (OR 7.96, CI 2.32–27.3, p = 0.001) were associated with the risk of clinically significant complications whereas the use of oral corticosteroids ≤30 days before the TBLC (OR 3.65, CI 0.911–14.6, p = 0.068) did not quite reach statistical significance. A history of serious cough was associated with the risk of pneumothorax (OR 4.18, CI 1.10–16.0, p = 0.036). Procedure associated mortality ≤90 days was 1%. Conclusions: The extent of traction bronchiectasis on HRCT and young age were associated with the risk of clinically significant complications whereas oral corticosteroid use did not quite reach statistical significance. A history of serious cough was associated with the risk of clinically significant pneumothorax.
- Published
- 2022
3. Reticulation pattern without honeycombing on high-resolution CT is associated with the risk of disease progression in interstitial lung diseases
- Author
-
Mononen, M. (Minna), Saari, E. (Eeva), Hasala, H. (Hannele), Kettunen, H.-P. (Hannu-Pekka), Suoranta, S. (Sanna), Nurmi, H. (Hanna), Kärkkäinen, M. (Miia), Selander, T. (Tuomas), Randell, J. (Jukka), Laurikka, J. (Jari), Uibu, T. (Toomas), Koskela, H. (Heikki), Kaarteenaho, R. (Riitta), Purokivi, M. (Minna), Mononen, M. (Minna), Saari, E. (Eeva), Hasala, H. (Hannele), Kettunen, H.-P. (Hannu-Pekka), Suoranta, S. (Sanna), Nurmi, H. (Hanna), Kärkkäinen, M. (Miia), Selander, T. (Tuomas), Randell, J. (Jukka), Laurikka, J. (Jari), Uibu, T. (Toomas), Koskela, H. (Heikki), Kaarteenaho, R. (Riitta), and Purokivi, M. (Minna)
- Abstract
Background: The disease course of idiopathic pulmonary fibrosis (IPF) is progressive and occasionally, other types of interstitial lung disease (ILD) may progress similarly to IPF. This study aimed to evaluate risk factors for disease progression within 24 months in patients with various ILDs. Methods: This prospective study obtained 97 patients with a suspected ILD who underwent a transbronchial lung cryobiopsy. The extent of several high-resolution computed tomography (HRCT) patterns was assessed. Due to the inclusion criteria the study population presented a low extent of honeycombing and definite usual interstitial pneumonia (UIP) pattern on HRCT suggesting an early stage of ILD. Disease progression within 24 months despite treatment was defined as a relative decline of ≥ 10% in forced vital capacity (FVC), or a relative decline in FVC of ≥ 5% and one of the three additional criteria: (1) a decline in diffusion capacity to carbon monoxide (DLCO) ≥ 15%; (2) increased fibrosis on HRCT; (3) progressive symptoms, or progressive symptoms and increased fibrosis on HRCT. The same definition was utilized in patients with IPF and other ILDs. Risk factors for disease progression were evaluated in a multivariable logistic regression model. Results: Disease progression was revealed in 52% of the patients with ILD, 51% of the patients with IPF, and 53% of the patients with other types of ILD. A high extent of reticulation on HRCT (Odds ratio [OR] 3.11, 95% Confidence interval [CI] 1.21–7.98, P = 0.019) and never smoking (OR 3.11, CI 1.12–8.63, P = 0.029) were associated with disease progression whereas platelet count (OR 2.06 per 100 units increase, CI 0.96–4.45, P = 0.065) did not quite reach statistical significance. Conclusion: Higher extent of reticulation on HRCT and never smoking appeared to associate with the risk of disease progression within 24 months in ILD patients without honeycombing. Approximately half of the patients with ILD revealed disease progress
- Published
- 2022
4. Apolipoprotein E and A-IV Polymorphisms in Ethnic Russians Living in Estonia*
- Author
-
Koivu, T. A., Uibu, T., Roto, P., Fan, Y.-M., Lehtinen, S., Jokela, H., Ehnholm, C., Nikkari, S. T., and Lehtimäki, T.
- Published
- 2004
5. Reticulation pattern without honeycombing on high-resolution CT is associated with the risk of disease progression in interstitial lung diseases.
- Author
-
Mononen M, Saari E, Hasala H, Kettunen HP, Suoranta S, Nurmi H, Kärkkäinen M, Selander T, Randell J, Laurikka J, Uibu T, Koskela H, Kaarteenaho R, and Purokivi M
- Subjects
- Disease Progression, Fibrosis, Humans, Prospective Studies, Tomography, X-Ray Computed methods, Idiopathic Pulmonary Fibrosis diagnosis, Lung Diseases, Interstitial diagnostic imaging
- Abstract
Background: The disease course of idiopathic pulmonary fibrosis (IPF) is progressive and occasionally, other types of interstitial lung disease (ILD) may progress similarly to IPF. This study aimed to evaluate risk factors for disease progression within 24 months in patients with various ILDs., Methods: This prospective study obtained 97 patients with a suspected ILD who underwent a transbronchial lung cryobiopsy. The extent of several high-resolution computed tomography (HRCT) patterns was assessed. Due to the inclusion criteria the study population presented a low extent of honeycombing and definite usual interstitial pneumonia (UIP) pattern on HRCT suggesting an early stage of ILD. Disease progression within 24 months despite treatment was defined as a relative decline of ≥ 10% in forced vital capacity (FVC), or a relative decline in FVC of ≥ 5% and one of the three additional criteria: (1) a decline in diffusion capacity to carbon monoxide (DLCO) ≥ 15%; (2) increased fibrosis on HRCT; (3) progressive symptoms, or progressive symptoms and increased fibrosis on HRCT. The same definition was utilized in patients with IPF and other ILDs. Risk factors for disease progression were evaluated in a multivariable logistic regression model., Results: Disease progression was revealed in 52% of the patients with ILD, 51% of the patients with IPF, and 53% of the patients with other types of ILD. A high extent of reticulation on HRCT (Odds ratio [OR] 3.11, 95% Confidence interval [CI] 1.21-7.98, P = 0.019) and never smoking (OR 3.11, CI 1.12-8.63, P = 0.029) were associated with disease progression whereas platelet count (OR 2.06 per 100 units increase, CI 0.96-4.45, P = 0.065) did not quite reach statistical significance., Conclusion: Higher extent of reticulation on HRCT and never smoking appeared to associate with the risk of disease progression within 24 months in ILD patients without honeycombing. Approximately half of the patients with ILD revealed disease progression, and similar proportions were observed in patients with IPF and in other types of ILD., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
6. Risk factors of clinically significant complications in transbronchial lung cryobiopsy: A prospective multi-center study.
- Author
-
Mononen M, Saari E, Hasala H, Kettunen HP, Suoranta S, Nurmi H, Randell J, Laurikka J, Uibu T, Koskela H, Kaarteenaho R, and Purokivi M
- Subjects
- Biopsy methods, Bronchoscopy adverse effects, Bronchoscopy methods, Cough etiology, Humans, Lung pathology, Prospective Studies, Risk Factors, Bronchiectasis etiology, Lung Diseases, Interstitial diagnosis, Pneumothorax epidemiology, Pneumothorax etiology, Pneumothorax pathology
- Abstract
Background: The use of a transbronchial lung cryobiopsy (TBLC) is increasing as a diagnostic method of interstitial lung diseases (ILD). This study aimed to evaluate risk factors associated with clinically significant complications of TBLC in ILD patients., Methods: Patients referred to Kuopio or Tampere university hospitals, in Finland, for a suspected ILD were included. The TBLC was performed in an outpatient setting for 100 patients. Patients were mechanically ventilated in general anesthesia. Fluoroscopy guidance and prophylactic bronchial balloon were used. Complications, such as bleeding, pneumothorax, infections, and mortality were recorded. Moderate or serious bleeding, pneumothorax, or death ≤90 days were defined as clinically significant complications. A multivariable model was created to assess clinically significant complications., Results: The extent of traction bronchiectasis (Odds ratio [OR] 1.30, Confidence interval [CI] 1.03-1.65, p = 0.027) and young age (OR 7.96, CI 2.32-27.3, p = 0.001) were associated with the risk of clinically significant complications whereas the use of oral corticosteroids ≤30 days before the TBLC (OR 3.65, CI 0.911-14.6, p = 0.068) did not quite reach statistical significance. A history of serious cough was associated with the risk of pneumothorax (OR 4.18, CI 1.10-16.0, p = 0.036). Procedure associated mortality ≤90 days was 1%., Conclusion: The extent of traction bronchiectasis on HRCT and young age were associated with the risk of clinically significant complications whereas oral corticosteroid use did not quite reach statistical significance. A history of serious cough was associated with the risk of clinically significant pneumothorax., (Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
7. Current Practice of Airway Stenting in the Adult Population in Europe: A Survey of the European Association of Bronchology and Interventional Pulmonology (EABIP)
- Author
-
Dutau, H. Breen, D. Bugalho, A. Dalar, L. Daniels, J. Dooms, C. Eberhardt, R. Ek, L. Encheva, M. Febvre, M. Hackl, M. Marran, S. Papai-Szekely, Z. Perch, M. Roglic, M. Rosell, A. Rozman, A. Shah, P.L. Simon, M. Szlubowski, A. Stratakos, G. Sundset, A. Uibu, T. Von Garnier, C. Zaric, B. Zdraveska, M. Zuccatosta, L. Bokan, D. Arshad Husain, S. Bilaceroglu, S. Gasche-Soccal, P. Gasparini, S. Herth, F.J.F. Munavvar, M.
- Abstract
Background: Airway stenting (AS) commenced in Europe circa 1987 with the first placement of a dedicated silicone airway stent. Subsequently, over the last 3 decades, AS was spread throughout Europe, using different insertion techniques and different types of stents. Objectives: This study is an international survey conducted by the European Association of Bronchology and Interventional Pulmonology (EABIP) focusing on AS practice within 26 European countries. Methods: A questionnaire was sent to all EABIP National Delegates in February 2015. National delegates were responsible for obtaining precise and objective data regarding the current AS practice in their country. The deadline for data collection was February 2016. Results: France, Germany, and the UK are the 3 leading countries in terms of number of centres performing AS. These 3 nations represent the highest ranked nations within Europe in terms of gross national income. Overall, pulmonologists perform AS exclusively in 5 countries and predominately in 12. AS is performed almost exclusively in public hospitals. AS performed under general anaesthesia is the rule for the majority of institutions, and local anaesthesia is an alternative in 9 countries. Rigid bronchoscopy techniques are predominant in 20 countries. Amongst commercially available stents, both Dumon and Ultraflex are by far the most commonly deployed. Finally, 11 countries reported that AS is an economically viable activity, while 10 claimed that it is not. Conclusion: This EABIP survey demonstrates that there is significant heterogeneity in AS practice within Europe. Therapeutic bronchoscopy training and economic issues/reimbursement for procedures are likely to be the primary reasons explaining these findings. © Copyright 2017 S. Karger AG, Basel. All rights reserved.
- Published
- 2018
8. Retroperitoneal and pleural fibrosis in an insulator working in power plants
- Author
-
Uibu, T., primary, Jantti, M., additional, Jarvenpaa, R., additional, Oksa, P., additional, Tossavainen, A., additional, Vanhala, E., additional, and Roto, P., additional
- Published
- 2009
- Full Text
- View/download PDF
9. Current Practice of Airway Stenting in the Adult Population in Europe: A Survey of the European Association of Bronchology and Interventional Pulmonology (EABIP).
- Author
-
Dutau H, Breen D, Bugalho A, Dalar L, Daniels J, Dooms C, Eberhardt R, Ek L, Encheva M, Febvre M, Hackl M, Marran S, Papai-Szekely Z, Perch M, Roglic M, Rosell A, Rozman A, Shah PL, Simon M, Szlubowski A, Stratakos G, Sundset A, Uibu T, Von Garnier C, Zaric B, Zdraveska M, Zuccatosta L, Bokan D, Arshad Husain S, Bilaceroglu S, Gasche-Soccal P, Gasparini S, Herth FJF, and Munavvar M
- Subjects
- Bronchoscopy instrumentation, Europe, Humans, Pulmonary Medicine instrumentation, Pulmonary Medicine methods, Pulmonary Medicine organization & administration, Surveys and Questionnaires, Bronchoscopy statistics & numerical data, Pulmonary Medicine statistics & numerical data, Stents statistics & numerical data
- Abstract
Background: Airway stenting (AS) commenced in Europe circa 1987 with the first placement of a dedicated silicone airway stent. Subsequently, over the last 3 decades, AS was spread throughout Europe, using different insertion techniques and different types of stents., Objectives: This study is an international survey conducted by the European Association of Bronchology and Interventional Pulmonology (EABIP) focusing on AS practice within 26 European countries., Methods: A questionnaire was sent to all EABIP National Delegates in February 2015. National delegates were responsible for obtaining precise and objective data regarding the current AS practice in their country. The deadline for data collection was February 2016., Results: France, Germany, and the UK are the 3 leading countries in terms of number of centres performing AS. These 3 nations represent the highest ranked nations within Europe in terms of gross national income. Overall, pulmonologists perform AS exclusively in 5 countries and predominately in 12. AS is performed almost exclusively in public hospitals. AS performed under general anaesthesia is the rule for the majority of institutions, and local anaesthesia is an alternative in 9 countries. Rigid bronchoscopy techniques are predominant in 20 countries. Amongst commercially available stents, both Dumon and Ultraflex are by far the most commonly deployed. Finally, 11 countries reported that AS is an economically viable activity, while 10 claimed that it is not., Conclusion: This EABIP survey demonstrates that there is significant heterogeneity in AS practice within Europe. Therapeutic bronchoscopy training and economic issues/reimbursement for procedures are likely to be the primary reasons explaining these findings., (© 2017 S. Karger AG, Basel.)
- Published
- 2018
- Full Text
- View/download PDF
10. Asbestos exposure as a risk factor for retroperitoneal fibrosis.
- Author
-
Uibu T, Oksa P, Auvinen A, Honkanen E, Metsärinne K, Saha H, Uitti J, and Roto P
- Published
- 2004
- Full Text
- View/download PDF
11. Outcomes of retroperitoneal fibrosis-related hydronephrosis and its risk factors for poor prognosis: a multi-center retrospective cohort study in Chinese patients.
- Author
-
Liu, Hongyan, Gao, Hui, Zhao, Jin-xia, Wong, Ut-kei, Liu, Shi-bo, Liu, Jian, Zhang, Ge, Wang, Kuan-ting, Wang, Yan, Zhao, Lin, Ma, Xiang-bo, Lu, Yue-wu, and Zhang, Xue-wu
- Published
- 2024
- Full Text
- View/download PDF
12. Asbestos fibers in para-aortic and mesenteric lymph nodes.
- Author
-
Uibu T, Vanhala E, Sajantila A, Lunetta P, Mäkelä-Bengs P, Goebeler S, Jäntti M, and Tossavainen A
- Subjects
- Aged, Aged, 80 and over, Asbestos, Amphibole analysis, Asbestosis metabolism, Body Burden, Humans, Inhalation Exposure adverse effects, Inhalation Exposure analysis, Lung pathology, Lung ultrastructure, Lymph Nodes pathology, Lymph Nodes ultrastructure, Male, Mesentery, Middle Aged, Mineral Fibers analysis, Occupational Diseases metabolism, Occupational Exposure, Retroperitoneal Space, Asbestos analysis, Asbestosis pathology, Lung chemistry, Lymph Nodes chemistry, Occupational Diseases pathology
- Abstract
Background: Asbestos fibers are known to accumulate in lung parenchyma and thoracic lymph nodes, but their presence and translocation into the extrapulmonary tissues need clarification. We assessed the presence of asbestos in the para-aortic (PA) and mesenteric (ME) lymph nodes., Methods: PA and ME lymph nodes and lung tissue from 17 persons who underwent medicolegal autopsy for suspicion of asbestos-related disease and from five controls were analyzed for asbestos fibers using transmission electron microscopy., Results: High concentrations of amphibole asbestos fibers were detected in several lung tissue samples and in the respective PA and ME lymph nodes. The mean concentration for the 10 persons with a lung asbestos content of >/=1 million fibers/g of dry tissue (f/g) was 0.85 (<0.05-4.36) million f/g in the PA lymph nodes and 0.55 (<0.02-2.86) million f/g in the ME lymph nodes. The respective mean values for the 12 persons with a lung asbestos concentration of <1 million f/g were 0.07 for the PA lymph nodes and 0.03 million f/g for the ME nodes. The lung asbestos burden that predicted the detection of asbestos in abdominal lymph nodes was 0.45 million f/g., Conclusions: In addition to their accumulation in lung tissue, asbestos fibers also collect in the retroperitoneal and the mesenteric lymph nodes. Even low-level occupational exposure results in the presence of crocidolite, amosite, anthophyllite, tremolite, or chrysotile in these abdominal lymph nodes. Our results support the hypothesis of lymph drainage as an important translocation mechanism for asbestos in the human body.
- Published
- 2009
- Full Text
- View/download PDF
13. A Review on The Role of Environmental Exposures in IgG4-Related Diseases.
- Author
-
Grasso C, Giacchero F, Crivellari S, Bertolotti M, and Maconi A
- Subjects
- Humans, Male, Female, Middle Aged, Environmental Exposure adverse effects, Immunoglobulin G, Immunoglobulin G4-Related Disease complications, Immunoglobulin G4-Related Disease pathology, Autoimmune Diseases, Retroperitoneal Fibrosis etiology, Retroperitoneal Fibrosis pathology, Asbestos adverse effects
- Abstract
Purpose of Review: Immunoglobulin G4-related diseases (IgG4-RDs) are immune-mediated fibroinflammatory multisystemic conditions identified by the presence of tumefactive lesions with a rich infiltrate of IgG4-positive plasma cells, and often by a high IgG4 serum concentration. IgG-RDs have a prevalence of at least 1 case every 100,000 persons, and they are mostly diagnosed after age 50, with a male to female ratio of about 3:1. IgG4-RD pathophysiology is still uncertain: it has been proposed that both genetic predisposition and chronic environmental exposures may play a role by triggering abnormal immune activation that perpetuates the disease. The purpose of this review is to summarize the evidences supporting the hypothesis that certain environmental/occupational exposures can trigger IgG4-RDs, focusing on the possible role of asbestos in an emerging IgG4-RD called idiopathic retroperitoneal fibrosis (IRF)., Recent Findings: Although some studies suggested a relationship between tobacco smoking and IgG4-RD risk, occupational exposures seem to have the most interesting effects. Positive history of blue-collar work increases the risk of developing an IgG4-RD, and mineral dusts and asbestos were the most strongly associated industrial compounds. Asbestos has been found to be a risk factor for IRF years before its classification as IgG4-RD, and later in two large case-control studies. In the most recent one, conducted on 90 patients and 270 controls, asbestos exposure conferred an increased IRF risk, quantified by odds ratios from 2.46 to 7.07. Further structured studies including serum IgG4 evaluation should be conducted to clarify the effect of asbestos on patients with confirmed diagnosis of IgG4-related IRF. Environmental exposures, especially of occupational origin, appear to play a role in the development of different types of IgG-RDs. In particular, although first suggested very recently, the relationship between asbestos and IRF deserves to be explored in more structured studies, especially because of the biological plausibility of the role of asbestos in IRF pathogenesis., (© 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.)
- Published
- 2023
- Full Text
- View/download PDF
14. Retroperitoneal and pleural fibrosis in an insulator working in power plants.
- Author
-
Uibu T, Jäntti M, Järvenpää R, Oksa P, Tossavainen A, Vanhala E, and Roto P
- Abstract
We describe a case history of a former insulator who developed concomitant retroperitoneal and pleural fibrosis. In his work, the patient had been exposed on a daily basis to asbestos dust while demolishing and installing pipeline insulations. The heavy asbestos exposure was confirmed by a high level of asbestos content in his autopsy lung sample. We propose that both retroperitoneal fibrosis and diffuse pleural thickening were induced in our patient by an abundant amount of amphibole asbestos fibres found in his lung and retroperitoneal tissues.
- Published
- 2009
- Full Text
- View/download PDF
15. Asbestos-related pleural and lung fibrosis in patients with retroperitoneal fibrosis.
- Author
-
Uibu T, Järvenpää R, Hakomäki J, Auvinen A, Honkanen E, Metsärinne K, Roto P, Saha H, Uitti J, and Oksa P
- Subjects
- Aged, Asbestosis complications, Asbestosis diagnostic imaging, Asbestosis etiology, Asbestosis pathology, Case-Control Studies, Environmental Exposure, Female, Fibrosis pathology, Humans, Male, Middle Aged, Pleural Diseases pathology, Pulmonary Fibrosis diagnostic imaging, Pulmonary Fibrosis pathology, Retroperitoneal Fibrosis diagnostic imaging, Retroperitoneal Fibrosis etiology, Retroperitoneal Fibrosis pathology, Tomography, X-Ray Computed, Asbestos adverse effects, Fibrosis etiology, Pleura pathology, Pleural Diseases etiology, Pulmonary Fibrosis etiology, Retroperitoneal Fibrosis complications
- Abstract
Background: Retroperitoneal fibrosis (RPF) is a rare fibroinflammatory disease that leads to hydronephrosis and renal failure. In a case-control study, we have recently shown that asbestos exposure was the most important risk factor for RPF in the Finnish population. The aim of this study was to evaluate the relation of asbestos exposure to radiologically confirmed lung and pleural fibrosis among patients with RPF., Methods: Chest high-resolution computed tomography (HRCT) was performed on 16 unexposed and 22 asbestos-exposed RPF patients and 18 asbestos-exposed controls. Parietal pleural plaques (PPP), diffuse pleural thickening (DPT) and parenchymal fibrosis were scored separately., Results: Most of the asbestos-exposed RPF patients and half of the asbestos-exposed controls had bilateral PPP, but only a few had lung fibrosis. Minor bilateral plaques were detected in two of the unexposed RPF patients, and none had lung fibrosis. DPT was most frequent and thickest in the asbestos-exposed RPF-patients. In three asbestos-exposed patients with RPF we observed exceptionally large pleural masses that were located anteriorly in the pleural space and continued into the anterior mediastinum.Asbestos exposure was associated with DPT in comparisons between RPF patients and controls (case-control analysis) as well as among RPF patients (case-case analysis)., Conclusion: The most distinctive feature of the asbestos-exposed RPF patients was a thick DPT. An asbestos-related pleural finding was common in the asbestos-exposed RPF patients, but only a few of these patients had parenchymal lung fibrosis. RPF without asbestos exposure was not associated with pleural or lung fibrosis. The findings suggest a shared etiology for RPF and pleural fibrosis and furthermore possibly a similar pathogenetic mechanisms.
- Published
- 2008
- Full Text
- View/download PDF
16. nCPAP treatment of obstructive sleep apnea increases slow wave sleep in prefrontal EEG.
- Author
-
Eskelinen V, Uibu T, and Himanen SL
- Subjects
- Adult, Female, Humans, Male, Middle Aged, Polysomnography, Statistics, Nonparametric, Continuous Positive Airway Pressure, Electroencephalography, Prefrontal Cortex physiopathology, Sleep Apnea, Obstructive physiopathology, Sleep Apnea, Obstructive therapy, Sleep Stages
- Abstract
According to standard sleep stage scoring, sleep EEG is studied from the central area of parietal lobes. However, slow wave sleep (SWS) has been found to be more powerful in frontal areas in healthy subjects. Obstructive sleep apnea syndrome (OSAS) patients often suffer from functional disturbances in prefrontal lobes. We studied the effects of nasal Continuous Positive Airway Pressure (nCPAP) treatment on sleep EEG, and especially on SWS, in left prefrontal and central locations in 12 mild to moderate OSAS patients. Sleep EEG was recorded by polysomnography before treatment and after a 3 month nCPAP treatment period. Recordings were classified into sleep stages. No difference was found in SWS by central sleep stage scoring after the nCPAP treatment period, but in the prefrontal lobe all night S3 sleep stage increased during treatment. Furthermore, prefrontal SWS increased in the second and decreased in the fourth NREM period. There was more SWS in prefrontal areas both before and after nCPAP treatment, and SWS increased significantly more in prefrontal than central areas during treatment. Regarding only central sleep stage scoring, nCPAP treatment did not increase SWS significantly. Frontopolar recording of sleep EEG is useful in addition to central recordings in order to better evaluate the results of nCPAP treatment.
- Published
- 2007
- Full Text
- View/download PDF
17. [Nontuberculous mycobacterial diseases--difficult to diagnose and difficult to treat].
- Author
-
Uibu T, Kellomäki L, Järvenpää R, Risto V, and Lumio J
- Subjects
- Adult, Anti-Bacterial Agents therapeutic use, Combined Modality Therapy, Female, Humans, Male, Middle Aged, Pneumonectomy methods, Prognosis, Radiography, Thoracic, Risk Assessment, Severity of Illness Index, Tomography, X-Ray Computed, Treatment Outcome, Mycobacterium isolation & purification, Mycobacterium Infections diagnosis, Mycobacterium Infections therapy, Pneumonia, Bacterial diagnosis, Pneumonia, Bacterial therapy
- Published
- 2005
18. Apolipoprotein E and A-IV polymorphisms in ethnic Russians living in Estonia.
- Author
-
Koivu TA, Uibu T, Roto P, Fan YM, Lehtinen S, Jokela H, Ehnholm C, Nikkari ST, and Lehtimäki T
- Subjects
- Estonia, Gene Frequency, Genotype, Humans, Isoelectric Focusing, Russia ethnology, Apolipoproteins A genetics, Apolipoproteins E genetics, Polymorphism, Genetic
- Abstract
137 Russians living in Estonia was screened by isoelectric focusing and immunoblotting procedures to determine the distribution of genetic variations in apolipoprotein E (apoE) and apolipoprotein A-IV (apoA-IV) genes. The apoA-IV-2 allele and epsilon4 allele frequency of the Russians tended to be lower than in most other European populations.
- Published
- 2004
19. [Snowstorm in the lungs].
- Author
-
Uibu T
- Subjects
- Adult, Humans, Male, Pulmonary Alveolar Proteinosis pathology, Pulmonary Alveolar Proteinosis physiopathology, Radiography, Remission, Spontaneous, Respiratory Function Tests, Dyspnea diagnosis, Pulmonary Alveolar Proteinosis diagnostic imaging
- Published
- 2001
20. Apolipoprotein E and A-IV polymorphisms in the Estonian population.
- Author
-
Lehtimäki T, Uibu T, Roto P, Koivula T, Jokela H, Ehnholm C, Peltonen N, and Nikkari T
- Subjects
- Alleles, Estonia, Gene Frequency, Humans, Phenotype, Apolipoproteins A genetics, Apolipoproteins E genetics, Polymorphism, Genetic
- Published
- 1998
- Full Text
- View/download PDF
21. Idiopathic Retroperitoneal Fibrosis: What Is the Optimal Clinical Approach for Long-Term Preservation of Renal Function?
- Author
-
Giannese, Domenico, Moriconi, Diego, Cupisti, Adamasco, Zucchi, Alessandro, Pastore, Antonio Luigi, Simonato, Alchiede, Mogorovich, Andrea, Claps, Francesco, and Bartoletti, Riccardo
- Subjects
RETROPERITONEAL fibrosis ,KIDNEY physiology ,URETERIC obstruction ,SURGICAL stents ,NEPHROSTOMY ,SURGICAL robots - Abstract
Background: The aim of this study was to investigate the long-term effects of ureteral stenting and the exact timing of stent removal in favor of surgery in patients with idiopathic retroperitoneal fibrosis (IRF). Summary: Medline research terms of "idiopathic retroperitoneal fibrosis" AND " medical therapy" OR "ureteral stenting" OR "surgical treatment" were done. Systematic reviews and observational and clinical studies were analyzed to obtain indication regarding the objective of the study for a narrative review. Ninety-two papers were analyzed. The treatment of IRF includes the monitoring of retroperitoneal fibrotic process spread and the prevention of abdominal organs entrapment. Treatment of ureteral obstruction includes medical therapy and ureteral stenting (US) or percutaneous nephrostomy (PNS) to overcome the worsening of renal function. Up to now, the timing of US or PNS removal is not yet clear, both for the complexity of evaluating the efficacy of the medical therapy and demonstrating the resolution of obstructive nephropathy. Moreover, it is not yet clear if the long-term ureteral stent placement or PNS is able to maintain an efficient renal function. Ureterolysis with a laparoscopic robot-assisted approach is now considered as an ultimate treatment for ureteral obstruction, limiting the progression of kidney impairment and improving the quality of life of patients, although nephrologists are generally abdicant regarding the potential switch toward the surgical approach. Key Messages: Prospective studies regarding the long-term effects of US on the renal function impairment in patients with IRF should be structured to obtain adequate information on the exact timing for the surgical approach. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
22. Effects of CPAP treatment on electroencephalographic activity in patients with obstructive sleep apnea syndrome during deep sleep: Preliminary findings of a cross-sectional study.
- Author
-
Li, Yiran, Li, Qi, Zou, Xueliang, Zhong, Zhijun, Ouyang, Qian, Zeng, Qinghong, Hu, Yinyin, Wang, Mengmeng, Luo, Yaxing, and Yao, Dongyuan
- Abstract
Study objectives: To investigate whether electroencephalographic (EEG) activities during non-rapid eye movement sleep stage 3 (N3) in obstructive sleep apnea syndrome (OSAS) patients were changed with continuous positive airway pressure (CPAP) treatment. Methods: A cross-sectional study of EEG activity during N3 sleep was conducted in 15 patients with moderate to severe OSAS without and with CPAP treatment compared to 15 normal controls. The amplitude, and absolute and relative power of delta, theta, alpha and beta waves as well as the absolute power ratio of slow to fast EEG waves (i.e., absolute power of delta and theta waves/absolute power of alpha and beta waves) and the spectral power density of 0-30 Hz EEG activities were analyzed. Results: CPAP significantly increased N3 sleep, the absolute and relative powers, amplitudes of delta and theta waves, and absolute power ratio of slow to fast EEG waves, but decreased relative alpha and beta powers during N3 sleep. However, there were no significant differences in those parameters between the OSAS patients with CPAP treatment and normal controls. Conclusions: CPAP prolongs N3 sleep and increases the power and amplitude of slow EEG waves during N3 sleep, which indicates an improvement in sleep quality and further provides evidence for recommendation of CPAP treatment for OSAS patients. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
23. Retroperitoneal fibrosis, a rare entity with urorenal and vascular subtypes – preliminary data.
- Author
-
Łoń, Izabela, Lewandowski, Jacek, Wieliczko, Monika, and Małyszko, Jolanta
- Subjects
RETROPERITONEAL fibrosis ,CARDIOVASCULAR diseases risk factors ,BLOOD cholesterol ,KIDNEY physiology ,RARE diseases - Abstract
Retroperitoneal fibrosis (RPF) is a rare disease associated with the formation of hard inflammatory and fibrous tissue in the retroperitoneum. Taking into consideration the fact that RPF is a rare disease with different subtypes, we compared the basal clinical and biochemical characteristics of the vascular and urorenal subtypes. From January 2005 until December 2021, 27 patients were identified as vascular subtype (18 males) and 11 as urorenal subtype (9 males). Patients with a primary urorenal origin had significantly worse kidney function as reflected by serum creatinine and eGFR (both p < 0.001); they also had higher serum cholesterol (p < 0.01). Hypertension, diabetes, hyperlipidemia and nicotinism were significantly more prevalent in vascular subtype (all p < 0.001). Vascular subtype is more prevalent in our study with more cardiovascular risk factor present. Due to the diversity of symptoms, diagnosis of RPF becomes a challenge for specialists as well as therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
24. Decreased absolute number of peripheral regulatory T cells in patients with idiopathic retroperitoneal fibrosis.
- Author
-
Lu Liu, Huanhuan Yan, Yanyan Wang, Yuhuan Xie, Lei Jiang, Jinfang Zhao, Chong Gao, Xiaofeng Li, and Caihong Wang
- Subjects
RETROPERITONEAL fibrosis ,REGULATORY T cells ,LYMPHOCYTE subsets ,TH2 cells ,B cells ,T helper cells - Abstract
Objective: In order to determine whether the immune balance of T helper 17 (Th17)/regulatory T(Treg) is related to the pathogenesis of idiopathic retroperitoneal fibrosis (IRPF), we analyzed the differences in peripheral blood lymphocytes, CD4+T cell subsets and cytokines between patients with IRPF and healthy people to clarify the CD4+T cell subsets, especially Treg cell subsets, and the role of cytokines in the pathogenesis of IRPF. Methods: This study included 22 patients with IRPF, 36 patients with IgG4-related diseases (IgG4-RD) without retroperitoneal fibrosis (RPF), and 28 healthy controls. The absolute numbers and percentage of peripheral blood lymphocyte subsets and CD4+T cell subsets in each group were detected by flow cytometry, and the serum cytokine level was detected by flow cytometric bead array (CBA). Results: Compared with the healthy group, the absolute value of B cells in peripheral blood of IRPF patients was significantly decreased, and T, natural killer (NK), CD4+ and CD8+ were not significantly abnormal. The absolute numbers of Th2 cells were lower than healthy group(p=0.043). In particular, the absolute numbers of Treg cells were significantly lower than healthy group (p<0.001), while the absolute numbers of Th17 cells increased(p=0.682). Th17/Treg was significantly higher than healthy group (p< 0.001). Cytokine analysis showed that the level of interleukin (IL)-4 in IRPF patients was higher than healthy group(p=0.011), IL-6, IL-10, IL-17, TNF-a and IFN-g were significantly higher than healthy group (all p<0.001). Receiver operating characteristic (ROC) curves showed that IL-10 and TNF-a could distinguish bilateral ureteral dilatation in IRPF patients, with areas under the ROC curve (AUCs) of 0.813 (95% CI:0.607-1.000, p=0.026) and 0.950 (95% CI:0.856-1.000, p=0.001), respectively. IL-6 could distinguish bilateral ureteral obstruction, with an AUC of 0.861 (95% CI: 0.682-1.000, p=0.015). Conclusions: Our study showed that IRPF patients had reduced Treg cells and indeed had Th17/Treg imbalance, which may be related to the pathogenesis of the disease. The levels of IL-6, IL-10 and TNF-a appear to be associated with the progression of IRPF. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
25. Bioengineering solutions for ureteric disorders: clinical need, challenges and opportunities.
- Author
-
Kapetanos, Konstantinos, Light, Alexander, Thakare, Niyukta, Mahbubani, Krishnaa, Saeb‐Parsy, Kasra, and Saeb‐Parsy, Kourosh
- Subjects
BIOENGINEERING ,HYBRID materials ,PLASTIC surgery ,GASTROINTESTINAL system ,IATROGENIC diseases ,URETERIC obstruction - Abstract
Objectives: To summarise the causes of ureteric damage and the current standard of care, discussing the risks and benefits of available therapeutic options. We then focus on the current and future solutions that can be provided by ureteric bioengineering and provide a description of the ideal characteristics of a bioengineered product. Methods: We performed a literature search in February 2021 in: Google Scholar, Medline, and Web of Science. Three searches were conducted, investigating: (a) the epidemiology of ureteric pathology, (b) the current standard of care, and (c) the state of the art in ureteric bioengineering. Results: The most‐common causes of ureteric damage are iatrogenic injury and external trauma. Current approaches to treatment include stent placement or surgical reconstruction. Reconstruction can be done using either urological tissue or segments of the gastrointestinal tract. Limitations include scarring, strictures, and infections. Several bioengineered alternatives have been explored in animal studies, with variations in the choice of scaffold material, cellular seeding populations, and pre‐implantation processing. Natural grafts and hybrid material appear to be associated with superior outcomes. Furthermore, seeding of the scaffold material with stem cells or differentiated urothelial cells allows for better function compared to acellular scaffolds. Some studies have attempted to pre‐implant the graft in the omentum prior to reconstruction, but this has yet to prove any definitive benefits. Conclusion: There is an unmet clinical need for safer and more effective treatment for ureteric injuries. Urological bioengineering is a promising solution in preclinical studies. However, substantial scientific, logistic, and economic challenges must be addressed to harness its transformative potential in improving outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
26. Idiopathic retroperitoneal fibrosis with endometrial cancer: a case report and literature review.
- Author
-
Si, Manfei, Zhang, Kun, Li, Jiaxin, He, Huiying, Yao, Ying, Han, Jinsong, and Qiao, Jie
- Abstract
Background: Retroperitoneal fibrosis is a rare disease characterized by chronic nonspecific inflammation, which leads to clinical compression manifestations of retroperitoneal organs especially ureter. Approximately 70 percent of retroperitoneal fibrosis cases are idiopathic which has no clear etiology. This study reported a rare case of a 48-year-old woman presented with idiopathic retroperitoneal fibrosis and endometrial cancer.Case Presentation: A 48-year-old woman presented with irregular vaginal bleeding without abdominal pain, bloating or discomfort. The patient was diagnosed iRPF after splenectomy 13 years ago. Then she took prednisone for 2 years and took tamoxifen for about 11 years. She stopped taking the medication from October 2019 to May 2020 and then started taking tamoxifen again until November 2020. Two weeks after she stopped taking tamoxifen, she presented with irregular vaginal bleeding. Gynecological ultrasound revealed a thick endometrium with uneven echo enhancement and blood flow signals. Then diagnostic curettage was performed with pathological examination showed endometroid carcinoma. Later, the patient was admitted to Peking University Third Hospital for surgery. Preoperative imaging examinations, including CT, MRI, and PET/CT, all showed pelvic enlarged lymph nodes and they were highly suspected to have lymph node metastasis. The patient underwent laparoscopic surgical staging and enlarged lymph nodes in the pelvic and aortic regions were removed. Finally, the pathology confirmed that endometrioid adenocarcinoma and fibrosis, but there was no tumor infiltration in these enlarged lymph nodes. The patient is now in good condition.Conclusion: This case report stressed the difficulty to distinguish between lymph node metastasis and inflammatory hyperplasia by common imaging methods. Due to increased surgical difficulty among retroperitoneal patients, lymphadenectomy should be carefully evaluated to avoid additional surgical complications and over-treatment. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
27. Retroperitoneal Fibrosis Is Still an Underdiagnosed Entity with Poor Prognosis.
- Author
-
Łoń, Izabela, Wieliczko, Monika, Lewandowski, Jacek, and Małyszko, Jolanta
- Subjects
RETROPERITONEAL fibrosis ,HYDRONEPHROSIS ,PROGNOSIS ,POSITRON emission tomography ,DIAGNOSIS ,MAGNETIC resonance imaging ,URETERIC obstruction - Abstract
Background: Retroperitoneal fibrosis (RPF) is a rare disease characterized by the presence of inflammatory and fibrous retroperitoneal tissue that often encircles abdominal organs including the aorta and ureters. Data on the incidence of this disease are limited. Summary: The disease may be idiopathic or secondary to infections, malignancies, drugs, or radiotherapy. The idiopathic form is an immune-mediated entity and a part of the broader spectrum of idiopathic diseases termed chronic periaortitis, characterized by a morphologically similar fibroinflammatory changes in the aorta and surrounding tissues. Taking into account the dominant symptoms and clinical characteristics of patients with periaortitis, 2 subtypes of disease could be distinguished. The vascular subtype includes patients with nondilated aorta or with inflammatory abdominal aortic aneurysm, both with and without involvement of adjacent structures and with numerous risk factors for atherosclerosis. In the renoureteral subtype, obstructive uropathy manifesting with hydronephrosis and acute kidney injury is the predominant finding. Due to the variety of symptoms, diagnosis of RPF remains challenging, difficult, and often delayed. A series of diagnostic tests should be performed, in order to confirm the diagnosis idiopathic RPF. Laboratory workup includes evaluation of inflammatory indices and immunological studies. A biopsy and histopathological evaluation may be necessary to confirm diagnosis and differentiate the disease. Computed tomography, magnetic resonance imaging, and positron emission tomography are the modalities of choice for the diagnosis and follow-up of this disease. Management of ureteral obstruction, hydronephrosis, and aortic aneurysms often requires surgical evaluation and treatment. The pharmacological treatment of RPF has been evaluated in a few randomized trials and is mainly based on observational studies. Steroid therapy remains the gold standard of treatment. Key Messages: Nowadays, multidisciplinary team approach with clinical and diagnostic experience in both primary and secondary RPF as well as 2 major subtypes should be offered. Centers specialized in rare diseases with collaboration with other units and referral system yield the best possible outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
28. association of smoking with immunoglobulin G4–related disease: a case–control study.
- Author
-
Wallwork, Rachel, Perugino, Cory A, Fu, Xiaoqing, Harkness, Tyler, Zhang, Yuqing, Choi, Hyon K, Stone, John H, and Wallace, Zachary S
- Subjects
RESEARCH ,CONFIDENCE intervals ,CASE-control method ,FIBROSIS ,RISK assessment ,MATHEMATICAL variables ,SMOKING ,LOGISTIC regression analysis ,ODDS ratio - Abstract
Objective To evaluate the association between cigarette smoking and the odds of IgG4-related disease (IgG4-RD). Methods We performed a case–control study of patients with IgG4-RD compared in a 1:5 ratio with age-, race- and sex-matched controls. We included cases evaluated at the Massachusetts General Hospital, a hospital within the Mass General Brigham (MGB) System. Controls were identified from the MGB Biobank. Smoking status at the date of IgG4-RD diagnosis or corresponding index date was determined. Conditional logistic regression was used to estimate the association between cigarette smoking and the odds of having IgG4-RD. Results There were 234 IgG4-RD cases and 1170 controls. The mean age (59 years), sex (62% male) and race (75% white) were well balanced. IgG4-RD cases were more likely to be current smokers compared with controls [25 (11%) vs 70 (6%); odds ratio (OR) 1.79 (95% CI 1.08, 2.95)]. This association was strongest among female cases [13 (14%) vs 19 (4%);, OR 3.79 (95% CI 1.71, 8.39)] and those with retroperitoneal fibrosis [RPF; 13 (28%) vs 13 (6%);, OR 6.93 (95% CI 2.78, 17.26)] or normal IgG4 concentrations [21 (21%) vs 21 (4%); OR 6.22 (95% CI 3.09, 12.49)]. When RPF cases were excluded, there was no longer an association between current smoking and the odds of having IgG4-RD [12 (6%) vs 57 (6%); OR 0.95 (95% CI 0.49, 1.86)]. Conclusion Being a current smoker is associated with greater odds of having IgG4-RD, especially among women and those with RPF or normal IgG4 concentrations. Current smoking is the first recognized modifiable risk factor for IgG4-RD. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
29. Idiopathic retroperitoneal fibrosis: an update for nephrologists.
- Author
-
Raglianti, Valentina, Rossi, Giovanni M., and Vaglio, Augusto
- Subjects
RETROPERITONEAL fibrosis ,AUTOIMMUNITY ,ADRENOCORTICAL hormones ,HYDRONEPHROSIS ,RITUXIMAB - Abstract
Idiopathic retroperitoneal fibrosis (IRF) is a rare condition characterized by the development of a peri-aortic and peri-iliac tissue showing chronic inflammatory infiltrates and pronounced fibrosis. Ureteral entrapment with consequent obstructive uropathy is one of the most common complications of IRF, which can lead to acute renal failure and, in the long term, to varying degrees of chronic kidney disease. IRF may be isolated or develop in association with autoimmune diseases (e.g. Hashimoto's thyroiditis and psoriasis) and other fibro-inflammatory disorders (often within the spectrum of immunoglobulin G4-related disease), which suggests that it should be considered as a potentially systemic condition. IRF is an immune-mediated disease: genetic variants (e.g. human leukocyte antigen (HLA)-DRB1*03) and environmental agents (mainly exposure to asbestos and smoking) are strongly associated with an increased risk of developing the disease, while a complex network of chemokines (e.g. CXCL12 and C-C moti chemokine 11 (CCL11)) and cytokines [e.g. interleukin (IL)-6, IL-12 and IL-13] is likely to orchestrate the inflammatory response and simultaneously promote fibrosis. Glucocorticoids, alone or in combination with traditional immunosuppressants such as methotrexate and mycophenolate mofetil, are usually efficacious and promptly induce disease remission; however, up to 50% of patients relapse, thus requiring repeat immunosuppressive courses. Biologic drugs, namely rituximab, are being explored for the treatment of IRF. In addition to medical therapies, interventional procedures (mainly ureteral stenting) are required to relieve ureteral obstruction, whereas surgical ureterolysis is generally reserved to refractory cases. If appropriately treated, then the overall and renal prognosis of IRF are good, with <5% patients developing end-stage renal disease. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
30. Natural Latxa Sheep Wool as an Environmentally Friendly Substitute for Specific Organic Fibers in Railway Friction Materials: A Preliminary Approach.
- Author
-
Monreal, Pablo, Oroz, Javier, Gutiérrez, Kike, and Clavería Ambroj, Isabel
- Subjects
WOOL ,FRICTION materials ,CELLULOSE fibers ,SHEEP ,FIBERS ,RAILROADS ,SCANNING electron microscopy - Abstract
The present work characterizes a natural sheep wool and compares its properties to those of a range of three different, well-known organic fibers that are typically used in the friction material production: aramid, cellulose, and polyacrylonitrile (PAN) fibers. The characterization work consisted of the study of the fibers alone, the nonpressed friction materials, and the final railway brake blocks. By these means, it was proven that the wool obtained from latxa sheep (Ovis aries) is a suitable replacement for cellulose because the wool presented slightly better thermal resistance in thermogravimetric analysis, and the particle retention ability of both fibers was similar. The latxa sheep wool was also found to delay the curing reaction to a similar degree as the PAN fiber. Finally, the friction material including sheep wool presented physical and mechanical properties similar to those including cellulose and PAN fibers, and no major differences were found in friction with changing speeds or temperatures. In addition, the inclusion of sheep wool led to the lowest speed and force fade and to a good recovery behavior after the speed and temperature phases, only second to the friction material using PAN fiber. An average spread in the instantaneous friction coefficient and a slightly higher wear are reported for the material containing sheep wool. Finally, no significant differences were found on the friction surfaces or on the wear mechanism when their microstructure was analyzed using scanning electron microscopy. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
31. Renal Involvement in Retroperitoneal Fibrosis: Prevalence, Impact and Management Challenges.
- Author
-
Mizushima, Ichiro and Kawano, Mitsuhiro
- Subjects
RETROPERITONEAL fibrosis ,KIDNEY failure ,CHRONIC kidney failure ,RETROPERITONEUM ,DISEASE complications ,URINARY organs - Abstract
Retroperitoneal fibrosis (RPF) is a rare disorder consisting of idiopathic and various secondary forms and characterized by chronic inflammatory infiltrates and marked fibrosis in the retroperitoneal space. In idiopathic RPF (IRPF), 35– 60% of cases have been reported to be IgG4-related RPF, the retroperitoneal lesions of IgG4-related disease (IgG4-RD). IRPF can frequently lead to renal insufficiency mediated by urinary tract obstruction and hydronephrosis irrespective of being IgG4-related or not. Clinical pictures, laboratory and imaging findings, and location of the urinary tract obstruction are generally similar in IgG4-related and non-IgG4-related IRPF although multiple organ involvement and serum IgG4 elevation may be characteristic of the IgG4-related forms. Periaortic/periarterial lesions are the most frequent cause of renal insufficiency. Although the response to glucocorticoids is generally good, relapse does occur in a considerable proportion of patients, and may require an additional immunosuppressive agent and/or urological intervention in cases with multiple relapses or refractory obstructive uropathy. In general, the prognosis of patients with IRPF is good, but careful attention needs to be paid to chronic kidney disease as a major complication and rupture of the affected aorta/artery as a life-threatening one. Further studies are necessary to better understand the pathogenesis of the disease and to establish the optimal diagnostic and therapeutic strategies for it. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
32. Ormond's disease accompanied by ankylosing spondylitis - a case report.
- Author
-
Żukowska, Paulina, Świerkot, Jerzy, Szmyrka, Magdalena, Sokolik, Renata, Wiland, Piotr, and Brzosko, Marek
- Subjects
RETROPERITONEAL fibrosis ,SYNDROMES ,ABDOMINAL pain ,PULMONARY veins ,SPONDYLITIS - Abstract
Idiopathic retroperitoneal fibrosis, or Ormond's disease, is a rare syndrome which is in essence the deposition of pathological fibrous tissue in the retroperitoneal space. In most cases, it is initially asymptomatic, but as the disease progresses, clinical symptoms develop. The main complaint are abdominal pain and symptoms resulting from the involvement of ureters, arterial and venous vessels. Diagnosis is based on computed tomography or magnetic resonance imaging, demonstrating a fibrotic tissue mass accumulated in the retroperitoneal space. Due to the typically late presentation of clinical symptoms, a diagnosis is difficult and is often made after complications occur. In our article, we present the case of a 71-year-old patient in whom coexisting ankylosing spondylitis and retroperitoneal fibrosis were diagnosed 15 years after non-specific abdominal pain occurred. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
33. Current approach to diagnosis and management of retroperitoneal fibrosis.
- Author
-
Tanaka, Toshiaki and Masumori, Naoya
- Subjects
RETROPERITONEAL fibrosis ,OPERATIVE surgery ,URETERIC obstruction ,ABDOMINAL aorta ,NEEDLE biopsy ,SURGICAL indications - Abstract
Retroperitoneal fibrosis is characterized by fibrotic lesions around the abdominal aorta and common ileac artery causing ureteral obstruction. Secondary retroperitoneal fibrosis is associated with malignant disease, drugs, exposure to radiation and surgery. In contrast, the majority of retroperitoneal fibrosis is classified into idiopathic retroperitoneal fibrosis, for which immunological etiology has been suggested. Recently, idiopathic retroperitoneal fibrosis has been considered to be a spectrum of immunoglobulin G4‐related disease, a systemic inflammatory disease, the concept of which has been developed during the past decade. In the management of retroperitoneal fibrosis, assessment of systemic lesions associated with immunoglobulin G4‐related disease and the exclusion of secondary retroperitoneal fibrosis is mandatory. Histological examination of retroperitoneal lesions is desired for accurate diagnosis and management. Laparoscopic or open biopsy is often beneficial, although it is more invasive than needle biopsy. Treatment for idiopathic retroperitoneal fibrosis consists of meticulous glucocorticoid therapy based on that for immunoglobulin G4‐related disease, which is expected to be highly effective. Ureteral obstruction is usually managed with conservative procedures, such as ureteral stenting or percutaneous nephrostomy. The goal of treatment for retroperitoneal fibrosis should be freedom from the stent/nephrostomy with withdrawal of the glucocorticoid in addition to salvage of renal function; however, conservative management does not always provide favorable outcomes. In contrast, aggressive surgical treatment, such as ureterolysis, can achieve the goal; however, the procedure is associated with high morbidity. Establishment of a consensus about treatment for idiopathic retroperitoneal fibrosis, including the optimal indications for the invasive surgical procedure and conservative management, is desired. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
34. RETROPERITONEAL FIBROSIS: A LITERATURE REVIEW.
- Author
-
Gómez Rivas, Juan, Miguel Quintana, Luis, Álvarez-Maestro, Mario, Aguilera, Alfredo, Martinez Piñeiro, Luis, and Sarikaya, Selçuk
- Published
- 2020
35. PROBLEMY W DIAGNOSTYCE ZWŁÓKNIENIA ZAOTRZEWNOWEGO.
- Author
-
Wieliczko, Monika and Chomicka, Inga
- Published
- 2019
36. Role of asbestos clearance in explaining long-term risk of pleural and peritoneal cancer: a pooled analysis of cohort studies.
- Author
-
Barone-Adesi, Francesco, Ferrante, Daniela, Chellini, Elisabetta, Merler, Enzo, Pavone, Venere, Silvestri, Stefano, Miligi, Lucia, Gorini, Giuseppe, Bressan, Vittoria, Girardi, Paolo, Ancona, Laura, Romeo, Elisa, Luberto, Ferdinando, Sala, Orietta, Scarnato, Corrado, Menegozzo, Simona, Oddone, Enrico, Tunesi, Sara, Perticaroli, Patrizia, and Pettinari, Aldo
- Abstract
Objectives: Models based on the multistage theory of cancer predict that rates of malignant mesothelioma continuously increase with time since first exposure (TSFE) to asbestos, even after the end of external exposure. However, recent epidemiological studies suggest that mesothelioma rates level off many years after first exposure to asbestos. A gradual clearance of asbestos from the lungs has been suggested as a possible explanation for this phenomenon. We analysed long-term trends of pleural and peritoneal cancer mortality in subjects exposed to asbestos to evaluate whether such trends were consistent with the clearance hypothesis.Methods: We used data from a pool of 43 Italian asbestos cohorts (51 801 subjects). The role of asbestos clearance was explored using the traditional mesothelioma multistage model, generalised to include a term representing elimination of fibres over time.Results: Rates of pleural cancer increased until 40 years of TSFE, but remained stable thereafter. On the other hand, we observed a monotonic increase of peritoneal cancer with TSFE. The model taking into account asbestos clearance fitted the data better than the traditional one for pleural (p=0.004) but not for peritoneal (p=0.09) cancer.Conclusions: Rates of pleural cancer do not increase indefinitely after the exposure to asbestos, but eventually reach a plateau. This trend is well described by a model accounting for a gradual elimination of the asbestos fibres. These results are relevant for the prediction of future rates of mesothelioma and in asbestos litigations. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
37. IgG4-related disease in patients with newly diagnosed idiopathic retroperitoneal fibrosis: a population-based Danish study.
- Author
-
Lomborg, N, Jakobsen, M, Bode, CS, Junker, P, and Bode, C S
- Subjects
RETROPERITONEAL fibrosis ,PLASMA cells ,DISEASES ,PATHOLOGY ,FIBROSIS - Abstract
Objectives: IgG4-related disease (IgG4-RD) may present as 'idiopathic' retroperitoneal fibrosis (IRPF). We aimed to determine the occurrence of IgG4-retroperitoneal fibrosis (IgG4-RPF) in a nationwide study on patients with newly diagnosed IRPF, and to compare histopathological, imaging, and clinical features in the IgG4-RPF and non-IgG4-RPF subsets. Method: The National Danish Pathology Register was searched for biopsy codes relating to retroperitoneal tissue from 1 January 2004 to 31 December 2013. Secondary causes of RPF were excluded. Among 724 candidate cases, 68 were identified with IRPF. Clinical, laboratory, and imaging recordings were reviewed, and tissue blocks were scrutinized for IgG4-RPF features according to international consensus. Results: Forty-two patients (28 males), median age 56 (25-74) years were included. Nineteen (45%) met the criteria for IgG4-RPF, seven with definite and 12 with possible IgG4-RPF, while 23 had non-IgG4-RPF. Local manifestations and laboratory measures did not differ between RPF subsets. Arterial hypertension (p = 0.037) and periaortic fibrosis (p = 0.024) were more common in IgG4-RPF vs non-IgG4-RPF. Plasma cell IgG4/total IgG ratios ≥ 40% were associated more with core histopathological features of IgG4-RD compared to ratios < 40% (p < 0.001). There was a positive correlation between tissue IgG4-positive plasma cells and eosinophil cell count in patients with IgG4-RPF (rho = 0.50, p = 0.043). Conclusion: Forty-five per cent of this nationwide study population with newly diagnosed IRPF could be reclassified with IgG4-RPF. The association between high numbers of IgG4-bearing plasma cells and histopathological features of IgG4-RPF supports IgG4-bearing plasma cells with a perturbed distribution between IgG4 and total IgG being implicated in the pathogenesis of IgG4-RPF. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
38. Long-term outcomes and predictors of a large cohort of idiopathic retroperitoneal fibrosis patients: a retrospective study.
- Author
-
Zhao, J, Li, J, and Zhang, Z
- Subjects
RETROPERITONEAL fibrosis ,DISEASE relapse ,PROGNOSIS ,HEALTH outcome assessment - Abstract
Objectives: Idiopathic retroperitoneal fibrosis (iRPF) is an uncommon disease with inflammatory features. Most patients have good prognosis but some may relapse or even progress to chronic renal failure. The aims of the study were to investigate the prognosis of a large cohort of iRPF patients and explore the risk factors for poor outcomes.Methods: All patients with a definite diagnosis of iRPF in Peking University First Hospital between 1 January 2003 and 31 December 2016 were enrolled. Their clinical and laboratory data at diagnosis and subsequent follow-up visits were collected. The endpoint of follow-up was defined as disease relapse or the last follow-up.Results: In total, 155 iRPF patients (45 females, 110 males) with a mean ± sd age of 55.1 ± 12 years at diagnosis were enrolled. The median duration of follow-up was 45.3 (0.1-169.2) months. During the whole follow-up, 27/153 (17.6%) patients encountered at least one relapse. Higher baseline erythrocyte sedimentation rate (ESR) was associated with a higher risk of relapse [p = 0.021, odds ratio (OR) = 1.016, 95% confidence interval (CI) 1.002-1.029]. A longer course of glucocorticoid treatment was associated with a lower risk of relapse (p = 0.030, OR = 0.948, 95% CI 0.904-0.995). Patients with a permanent presence of hydronephrosis were more likely to develop renal atrophy (33/154 vs 19/51, χ2 = 5.069, p = 0.024).Conclusions: Higher baseline ESR and a shorter course of glucocorticoid treatment seemed to be predictors of relapse in iRPF patients. Prompt release of hydronephrosis to prevent kidney atrophy is very important for preserving renal function and improving the prognosis. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
39. Retroperitoneal fibrosis: the clinical, laboratory, and radiographic presentation.
- Author
-
Scheel PJ Jr and Feeley N
- Subjects
- Adult, Aged, Aorta, Abdominal diagnostic imaging, Blood Sedimentation, Cohort Studies, Female, Humans, Iliac Artery diagnostic imaging, Male, Middle Aged, Peritoneum diagnostic imaging, Prospective Studies, Retroperitoneal Fibrosis classification, Risk Factors, Tomography, X-Ray Computed, Antibodies, Antinuclear blood, Hemoglobins metabolism, Retroperitoneal Fibrosis blood, Retroperitoneal Fibrosis diagnostic imaging
- Abstract
Retroperitoneal fibrosis (RPF) is an inflammatory disorder that affects the infrarenal great vessels and surrounding structures. Although first described in 1948 by Ormond, much of the information currently available on this disease is conflicting and results from multiple definitions used by different investigators. We conducted the current study to describe the clinical, laboratory, and radiographic presentation of RPF from a single center using data collected in a prospective fashion.Data on all patients who were referred to our RPF clinic were prospectively collected. We obtained information on presenting signs and symptoms, and on the presence or absence of "traditional risk factors," comorbidities, and family histories. All patients underwent the same battery of laboratory testing, including complete blood count, renal function profile, erythrocyte sedimentation rate (ESR), thyroid-stimulating hormone, and antinuclear antibodies (ANA). All patients had contrast-enhanced computed tomography (CT) or magnetic resonance imaging (MRI) of the abdomen and pelvis. The extent of disease was classified based on the anatomic location of the soft-tissue density.Forty-eight patients (26 male and 22 female) met the criteria for RPF and were included in the study. The mean age was 54.25 years. Few patients had traditional risk factors for RPF. Pain and weight loss were the most common presenting symptoms. The mean hemoglobin was 11.6 g/dL. The mean ESR was 40.5 mm/h. Nine patients had positive ANA, all with negative antibodies to dsDNA. CT or MRI revealed the presence of a periaortic soft-tissue density in all (100%) patients; 69% had pericaval involvement, 62% had obstruction of 1 or both ureters, and 35% of patients had involvement of the renal artery or renal vein.In the current report we present the demographics and laboratory and radiographic presentation of a homogenous group of patients with RPF. We attempt to solidify a proper scheme of classification for the disease, and suggest an anatomic classification system that may be used for future studies.
- Published
- 2009
- Full Text
- View/download PDF
40. Rituximab for idiopathic and IgG4-related retroperitoneal fibrosis.
- Author
-
Wallwork, Rachel, Wallace, Zachary, Perugino, Cory, Sharma, Amita, and Stone, John H.
- Published
- 2018
- Full Text
- View/download PDF
41. Pleural abnormalities and exposure to elongate mineral particles in Minnesota iron ore (taconite) workers.
- Author
-
Perlman, David, Mandel, Jeffrey H., Odo, Nnaemeka, Ryan, Andy, Lambert, Christine, MacLehose, Richard F., Ramachandran, Gurumurthy, and Alexander, Bruce H.
- Subjects
MINERS ,TACONITE mines & mining ,PLEURA diseases ,MINERALS ,DUST diseases ,AMPHIBOLES ,DISEASES - Abstract
Background: Iron ore (taconite) mining and processing are an important industry in northern Minnesota and western Michigan. Concerns around exposures have centered largely on exposure to non‐asbestiform amphibole elongate mineral particles (EMPs) found in the eastern portion of the Minnesota iron range. Methods: A cross sectional survey was undertaken of current and former taconite workers and spouses along with a detailed exposure assessment. Participants provided an occupational history and had a chest radiograph performed. Results: A total of 1188 workers participated. Potential exposures to non‐amphibole EMPs were evident across multiple jobs in all active mines. Pleural abnormalities were found in 16.8% of workers. There was an association of pleural abnormalities with cumulative EMP exposure that was not specific to the eastern portion of the range. Conclusion: There was evidence of a mild to moderate increase in pleural abnormalities in this population of miners, associated with geographically non‐specific cumulative EMP exposure. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
42. Bosnian study of APOE distribution (BOSAD): a comparison with other European populations.
- Author
-
Adler, Grażyna, Adler, Mateusz A., Urbańska, Anna, Skonieczna-Żydecka, Karolina, Kiseljakovic, Emina, Valjevac, Amina, Parczewski, Miłosz, and Hadzovic-Dzuvo, Almira
- Subjects
APOLIPOPROTEIN E ,GENOTYPES ,ALLELES ,GENETIC polymorphisms - Abstract
Background:The ε2, ε3 and ε4 alleles ofAPOEgene have been associated with several diseases in different populations. Data on the frequency of alleles are used in both a clinical and evolutionary context. Although the data on frequency of these alleles are numerous, there are no reports for the population of Bosnia and Herzegovina. Aim:To estimate the frequency ofAPOEalleles in a healthy Bosnian population and compare it to data for other European populations. Subjects and Methods:Overall, 170 unrelated Bosnian subjects (108 female and 62 male), aged 53.0 (±5.0) years were included in this study. Genotypes were determined by real-time PCR. Results:In our group the prevalence of heterozygotes E2/E3, E2/E4 and E3/E4 was 20.6%, 3.5% and 12.9%, respectively, while the prevalence of homozygotes E2/E2, E3/E3, E4/E4 was 0.6%, 61.2% and 1.2%, respectively, with a mean frequency of ε2, ε3 and ε4 alleles of 12.6%, 78.0% and 9.4%, respectively. Conclusions:In studied European populations we observed a linear, gradually increasing trend in the frequency of ε4 allele from South to North (Pearson’s test 0,7656,pvalue <0.00001), and the Bosnian population fits into this pattern perfectly. [ABSTRACT FROM PUBLISHER]
- Published
- 2017
- Full Text
- View/download PDF
43. Neue (und alte) Aspekte der retroperitonealen Fibrose.
- Author
-
Brandt, A., Dreger, N., Müller, E., Kukuk, S., Roth, S., Brandt, A S, Dreger, N M, and Müller, E
- Abstract
Copyright of Der Urologe A is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2017
- Full Text
- View/download PDF
44. TRATAMIENTO LAPAROSCOPICO DE LA FIBROSIS RETROPERITONEAL.
- Author
-
Hernández Fernández, Carlos, Subirá Rios, David, Moralejo Gárate, Mercedes, Rodríguez Fernández, Elena, Caño Velasco, Jorge, and Herranz Amo, Felipe
- Published
- 2017
45. Current Practice of Airway Stenting in the Adult Population in Europe:A Survey of the European Association of Bronchology and Interventional Pulmonology (EABIP)
- Author
-
Dutau, Hervé, Breen, David, Bugalho, Antonio, Dalar, Levent, Daniels, Johannes, Dooms, Christophe, Eberhardt, Ralf, Ek, Lars, Encheva, Milena, Febvre, Michel, Hackl, Martin, Marran, Sirje, Papai-Szekely, Zsolt, Perch, Michael, Roglic, Mihovil, Rosell, Antoni, Rozman, Ales, Shah, Pallav L, Simon, Marioara, Szlubowski, Artur, Stratakos, Grigoris, Sundset, Arve, Uibu, Toomas, Von Garnier, Christophe, Zaric, Bojan, Zdraveska, Marija, Zuccatosta, Lina, Bokan, Darijo, Arshad Husain, Syed, Bilaceroglu, Semra, Gasche-Soccal, Paola, Gasparini, Stefano, Herth, Felix J F, Munavvar, Muhammed, Dutau, Hervé, Breen, David, Bugalho, Antonio, Dalar, Levent, Daniels, Johannes, Dooms, Christophe, Eberhardt, Ralf, Ek, Lars, Encheva, Milena, Febvre, Michel, Hackl, Martin, Marran, Sirje, Papai-Szekely, Zsolt, Perch, Michael, Roglic, Mihovil, Rosell, Antoni, Rozman, Ales, Shah, Pallav L, Simon, Marioara, Szlubowski, Artur, Stratakos, Grigoris, Sundset, Arve, Uibu, Toomas, Von Garnier, Christophe, Zaric, Bojan, Zdraveska, Marija, Zuccatosta, Lina, Bokan, Darijo, Arshad Husain, Syed, Bilaceroglu, Semra, Gasche-Soccal, Paola, Gasparini, Stefano, Herth, Felix J F, and Munavvar, Muhammed
- Abstract
BACKGROUND: Airway stenting (AS) commenced in Europe circa 1987 with the first placement of a dedicated silicone airway stent. Subsequently, over the last 3 decades, AS was spread throughout Europe, using different insertion techniques and different types of stents.OBJECTIVES: This study is an international survey conducted by the European Association of Bronchology and Interventional Pulmonology (EABIP) focusing on AS practice within 26 European countries.METHODS: A questionnaire was sent to all EABIP National Delegates in February 2015. National delegates were responsible for obtaining precise and objective data regarding the current AS practice in their country. The deadline for data collection was February 2016.RESULTS: France, Germany, and the UK are the 3 leading countries in terms of number of centres performing AS. These 3 nations represent the highest ranked nations within Europe in terms of gross national income. Overall, pulmonologists perform AS exclusively in 5 countries and predominately in 12. AS is performed almost exclusively in public hospitals. AS performed under general anaesthesia is the rule for the majority of institutions, and local anaesthesia is an alternative in 9 countries. Rigid bronchoscopy techniques are predominant in 20 countries. Amongst commercially available stents, both Dumon and Ultraflex are by far the most commonly deployed. Finally, 11 countries reported that AS is an economically viable activity, while 10 claimed that it is not.CONCLUSION: This EABIP survey demonstrates that there is significant heterogeneity in AS practice within Europe. Therapeutic bronchoscopy training and economic issues/reimbursement for procedures are likely to be the primary reasons explaining these findings.
- Published
- 2018
46. IgG4-related retroperitoneal fibrosis: a newly characterized disease.
- Author
-
Lian, Linjuan, Wang, Cong, and Tian, Jian‐li
- Subjects
RETROPERITONEAL fibrosis ,RETROPERITONEUM diseases ,COLLAGEN diseases ,FIBROSIS ,ARTERIES - Abstract
Retroperitoneal fibrosis ( RPF) is a rare disease characterized by chronic, nonspecific inflammatory and sclerotic or fibrotic tissue in the periaortic or periiliac retroperitoneum that encases adjacent structures. There will be a series of clinical manifestations once the proliferated fibrous tissues encase the abdominal aorta, iliac arteries and urinary duct. RPF is generally divided into two types: idiopathic retroperitoneal fibrosis ( IRPF) without identified pathogenesis, making up about two-thirds of cases, and secondary retroperitoneal fibrosis. Recent studies on Immunoglobulin G4-related disease (IgG4- RD) reveal that abundant infiltration of IgG4 positive plasma cells is found in biopsies on the mass of RPF of some IRPF patients, which is identified as one spectrum of IgG4- RD and is named IgG4-related RPF. IgG4-related RPF is often misdiagnosed as retroperitoneal visceral malignancy and is treated with surgery. In addition, because of its good response to glucocorticoid, early detection and treatment is important. We review the definition, epidemiology, clinical features, diagnostic criteria, treatment and prognosis of IgG4-related RPF in this article to raise awareness of this newly characterized disease. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
47. Quantitative structure–mesothelioma potency model optimization for complex mixtures of elongated particles in rat pleura: A retrospective study.
- Author
-
Cook, Philip M., Swintek, Joseph, Dawson, Timothy D., Chapman, David, Etterson, Mathew A., and Hoff, Dale
- Subjects
MESOTHELIOMA ,PLEURA diseases ,ASBESTOS fibers ,LABORATORY rats ,QUANTITATIVE research ,TRANSMISSION electron microscopy - Abstract
Cancer potencies of mineral and synthetic elongated particle mixtures, including asbestos fibers, are influenced by changes in fiber dose composition, bioavailability, and biodurability in combination with relevant cytotoxic dose-response relationships. An extensive rat intrapleural dose characterization data set with a wide variety of elongated particles physicochemical properties facilitated statistical analyses of pleural mesothelioma response data combined from several studies for evaluation of alternative dose-response models. Utilizing logistic regression of individual elongated particle dimensional variations within each test sample, four major findings emerged: (1) Mild acid leaching provides superior prediction of tumor incidence compared to samples that were not leached; (2) sum of the elongated particle surface areas from mildly acid-leached samples provides the optimum holistic dose-response model; (3) progressive removal of dose associated with very short and/or thin elongated particles significantly degrades the resultant particle count and surface area dose-based predictive model fits; and (4) alternative biologically plausible model adjustments provide evidence for reduced potency of elongated particles with aspect ratios less than 8 and lengths greater than 80 µm. Regardless of these adjustments, the optimum predictive models strongly incorporate potency attributable to abundant short elongated particles in proportion to their surface area. Transmission electron microscopy analyses of low-temperature-ashed pleural membrane and lung tissues 5.5 mo post intrapleural exposures do not support hypotheses that short elongated particles that reach the pleural space are rapidly eliminated. Low-aspect-ratio elongated particles were still abundant in pleural membrane tissues but may have reduced potencies due to aggregation tendencies and therefore lower potential for intracellular presence. [ABSTRACT FROM PUBLISHER]
- Published
- 2016
- Full Text
- View/download PDF
48. Predicting pulmonary fibrosis in humans after exposure to multi-walled carbon nanotubes (MWCNTs).
- Author
-
Sharma, Monita, Nikota, Jake, Halappanavar, Sabina, Castranova, Vincent, Rothen-Rutishauser, Barbara, and Clippinger, Amy
- Subjects
PULMONARY fibrosis ,MULTIWALLED carbon nanotubes ,TOXICOLOGY ,TOXICOLOGY of poisonous gases - Abstract
The increased production and use of multi-walled carbon nanotubes (MWCNTs) in a diverse array of consumer, medical, and industrial applications have raised concerns about potential human exposure to these materials in the workplace and ambient environments. Inhalation is a primary route of exposure to MWCNTs, and the existing data indicate that they are potentially hazardous to human health. While a 90-day rodent inhalation test (e.g., OECD Test No. 413: subchronic inhalation toxicity: 90-day study or EPA Health Effects Test Guidelines OPPTS 870.3465 90-day inhalation toxicity) is recommended by the U.S. Environmental Protection Agency Office of Pollution Prevention and Toxics for MWCNTs (and other CNTs) if they are to be commercially produced (Godwin et al. in ACS Nano 9:3409-3417, ), this test is time and cost-intensive and subject to scientific and ethical concerns. As a result, there has been much interest in transitioning away from studies on animals and moving toward human-based in vitro and in silico models. However, given the multiple mechanisms of toxicity associated with subchronic exposure to inhaled MWCNTs, a battery of non-animal tests will likely be needed to evaluate the key endpoints assessed by the 90-day rodent study. Pulmonary fibrosis is an important adverse outcome related to inhalation exposure to MWCNTs and one that the non-animal approach should be able to assess. This review summarizes the state-of-the-science regarding in vivo and in vitro toxicological methods for predicting MWCNT-induced pulmonary fibrosis. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
49. Predicting Long-Term Asbestos Prevalence in Human Lungs, Lymph Nodes, and Remote Organs from Short-Term Murine Experiments.
- Author
-
DeStefano A, Martin C, Huang A, and Wallace D
- Subjects
- Animals, Environmental Exposure, Humans, Mice, Particulate Matter metabolism, Prevalence, Rats, Time, Asbestos metabolism, Lung chemistry, Lymph Nodes chemistry, Models, Biological
- Abstract
Inhalation of asbestos fibers leads to a suite of fatal diseases that can manifest years, if not decades, after cessation of exposure. The first phase of disease progression occurs as fibers are transported from point of entry in the lungs throughout the entire body. A mathematical model is developed for the disposition of non-chrysotile asbestos in the body and, except for exposure levels, is parameterized by published data on short-term rat experiments. Asbestos exposure in individual humans is determined by matching published long-term lung data for nine patients. The resulting model predicts transport of fibers within the lymphatic system and prevalence of fibers in lymph nodes for these patients with reasonable accuracy. Model predictions for remote organs are compared against published observations. The model consists of a system of globally stable differential equations, and a sensitivity analysis was conducted. The model indicates that fiber density in lymph nodes is correlated with total exposure, level times duration, no matter whether there is a long-term, low-level exposure or short-term, high-level exposure. The model predicts that levels of sequestered asbestos reach steady state within five years of cessation of exposure, a timeline previously not known. The model suggests that the time to steady state is short compared to onset of disease, and that delayed onset of related disease may be a function of chemical and biological processes not in this model.
- Published
- 2021
- Full Text
- View/download PDF
50. Spectrum of Lymph Node Lesions by Fine Needle Aspiration Cytology in Worker Population of Eastern Zone of India.
- Author
-
MALLICK, DEBJANI, NATHPRASAD, RABINDRA, GON, SONIA, and GHOSH, GAYATRI
- Subjects
LYMPH nodes ,NEEDLE biopsy ,LYMPHADENITIS ,TUMORS ,CARCINOMA - Abstract
Evaluation of lymphadenopathy is of clinical significance as the underlying disease may range from a treatable infectious etiology to malignant neoplasm. The aim and objective of the present study was to evaluate palpable lymph nodes of population working in small to medium scale industries represented as Group A by Fine Needle Aspiration Cytology (FNAC) and to compare the results with the general population designated as Group B comprising dependent non-working family members of Group A population. The results were categorized into two main headings of benign and malignant diseases with sub categorization. The prevalence of benign diagnoses in Group A and Group B was 81% and 79% respectively while that of malignant diagnoses in Group A & Group B was 19% and 21% respectively. The predominant cause of lymphadenopathy in Group A & Group B was reactive lymphadenitis, followed by tubercular lymphadenitis respectively. Metastatic carcinoma was the commonest malignant neoplasm (Group A-16.31% & Group B-17.33%) followed by Non Hodgkins lymphoma (Group A-2.63% & Group B-2.89%). Squamous cell carcinoma was the commonest cytological type in metastatic carcinoma. Surprisingly, the Group A had a decade earlier incidence of metastasis compared to the general population represented by Group B. Early and continuous exposure to the carcinogens among the workers may be the cause of early occurrence of malignancy. FNAC being an easy and reliable procedure is recommended for screening of lymph node lesion of the worker population for early diagnosis and management. [ABSTRACT FROM AUTHOR]
- Published
- 2015
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.